High Risk of Hepato-Pancreato-Biliary Cancers in Patients with Inflammatory Bowel Disease

Informative video on increased risk of Hepato-Pancreato-Biliary Cancers with IBD

High Risk of Hepato-Pancreato-Biliary Cancers in Patients with Inflammatory Bowel Disease

Informative video-capsule that presents the results of a large-scale study that evaluated the absolute and relative incidences of hepato-pancreato-biliary cancers in patients with inflammatory bowel disease with or without primary sclerosing cholangitis.
To read more on this article 

Referências

1. Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P. et al. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study. United European Gastroenterol J. 2022;10(2):212–24. Available at: https://onlinelibrary.wiley.com/doi/10.1002/ueg2.12204